MEASURING TREATMENT PROGRESS IN THERAPEUTIC COMMUNITIES

这是NIDA科学家发展奖（SDA）的申请。 候选人：大卫Kressel博士获得博士学位。在纽约市立大学的社会学专业 1992年10月毕业。 从那时起，Kressel博士一直致力于 作为治疗社区中心的首席研究助理， 国家发展研究院（CTCR） （NDRI），他一直在研究药物滥用的“准备” 治疗、治疗中的保留和治疗效果。 环境：研究地点，NDRI的CTCR提供了丰富，多样的 刺激的环境。 NDRI拥有30多名博士学位。 水平 1993年，科学家们进行了20多项资助赠款。 的 候选人将接受乔治德勒旺的指导、培训和支持， 博士他将担任导师。 德莱昂博士是CTCR的主任， 国际公认的TC研究领域的权威。 主要研究目的是进行实证研究 治疗社区（TC）的治疗过程。 在颁奖结束时 在此期间，候选人将提供实地测试，心理测量完善， 通过TC治疗对患者进展的经验性测量。 这将是 在三个技术合作地点进行了两次试点研究。 这些 将在一个新出现的框架内制定衡量标准， 康复和治疗阶段理论。 职业发展;候选人将获得研究科学和 在获奖期间，通过参加两个主要的 研究工作。 第一个将是广泛的二次分析， 从9800多名受试者中收集的客户治疗准备数据， 12个包括妇女和种族/族裔在内的特殊药物滥用者群体 18个不同的研究项目。 第二个项目是 实验评估仪器的影响， 三种技术合作模式的匹配/转诊决定：长期 居住（至少12个月）;短期居住（3-9个月）， 不住院治疗。 资助继续研究治疗过程 在授予期之后，候选人将提交一份建议书， 新的治疗进展规模涉及更广泛的治疗 模式和客户群体。 意义：两项拟议试点研究的研究结果 将为更大规模的计划研究提供经验基础， 候选人现场测试治疗进展仪器在几个 治疗社区计划网站。 本次现场测试的结果将是 这些程序用于治疗计划和评估。 更 总的来说，SDA将为职业生涯提供基础， 开展系统性研究举措，增进对药物治疗的了解 过程 候选人希望他的研究能大大增加 科学文献和作出实际贡献，以改善 药物滥用治疗 需要过程仪表来解决 提高治疗保留率和建立匹配的问题 客户和治疗模式之间的关系。

This is a request for a NIDA Scientist Development Award (SDA). Candidate: Dr. David Kressel received his Ph.D. in sociology at the CUNY Graduate Center in October 1992. Since then Dr. Kressel has been working as Principal Research Associate at the Center for Therapeutic Community Research (CTCR) at National Development and Research Institutes, Inc. (NDRI) where he has been studying "readiness" for substance abuse treatment, retention in treatment and treatment efficacy. Environment: The research location, CTCR at NDRI provides a rich, diverse and stimulating environment. NDRI houses more than 30 Ph.D. level scientists, who in 1993, conducted more than 20 funded grants. The candidate will receive guidance, training and support from George De Lewon, ph.D. who will act as preceptor. Dr. De Leon is CTCR's Director and an internationally acknowledged authority in the field of TC research. Research; The major research aim is to conduct an empirical investigation into therapeutic community (TC) treatment process. By the end of the award period the candidate will provide field tested, psychometrically refined empirical measures of client progress through TC treatment. This will be accomplished by conducting two pilot studies at three TC locations. These measurements will be developed within a framework of newly emerging recovery and treatment stage theories. Career Development; The candidate will acquire research science and management skills during the award period by participating in two major research efforts. The first will be an extensive secondary analysis of client readiness for treatment data collected on over 9800 subjects from 12 special population of drug abusers including women and racial/ethnic minorities in 18 different research projects. The second project will experimentally evaluate the impact of an instrument for guiding matching/referral decisions to three TC oriented modalities: long term residential (at least 12 months); short term residential (3-9 months) and non-residential treatment. To fund continued study of treatment process beyond the award period the candidate will submit a proposal to validate the new treatment progress scales involving a wider range of treatment modalities and client populations. Significance: The research finding from the two proposed pilot studies will provide the empirical basis for a basis for a larger planned study by the candidate to field test treatment progress instruments in several therapeutic community program sites. Results form this field test will be utilized by these programs for treatment planning and assessment. More broadly, the SDA will provide the foundation for a career focused on systematic research initiatives to advance understanding of drug treatment process. The candidate intends for his research to add substantially to the scientific literature and make practical contributions to improving substance abuse treatment. Process instrumentation is needed to address issues of enhancing retention in treatment and establishing the match between client and treatment modalities.